Particularly, the MET receptor tyrosine kinase (RTK) for hepatocyte growth factor (HGF) represents a model recapitulating both the classically associated functions of RTKs in cancer, as well as their involvement in rewiring the DDR machinery. The gene discussed is MET; the disease is cancer.